Brief: Onxeo announces another positive DSMB recommendation for Livatag

Valerio Therapeutics SA

21/11/2016 17:01

Nov 21 (Reuters) - Onxeo SA  C4X.PA : 
    * Announces 9th positive DSMB recommendation to continue 
Livatag relive phase III trial in HCC 
    * Nine consecutive positive DSMB recommendations reinforce 
acceptable safety profile of Livatag 
 
Source text for Eikon:  ID:nBw2gz0Gca  
Further company coverage:  C4X.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))